Use of monoclonal antibodies and functional assays for prediction of risk of opportunistic infection
OwnerJoann Trial, Roger Rossen +1inventors
InventorsJoann Trial, Roger Rossen, Holly Birdsall
Life of this patent
Estimating the term…
Loading patent…
OwnerJoann Trial, Roger Rossen +1inventors
InventorsJoann Trial, Roger Rossen, Holly Birdsall
Estimating the term…
The present invention is drawn to methods of detecting and monitoring a subject at risk for opportunistic infection. More particularly, the methods comprise monitoring key monocyte functions and surrogate cell surface markers on monocytes to predict subjects at risk for opportunistic infection. Specific monocyte key functions comprise measurements of phagocytic activity and transendothelial migration. Another aspect of the present invention is a kit comprising the compositions of the present invention used to detect or monitor a subject at risk for opportunistic infection.
A method of detecting a subject at risk for opportunistic infection comprising the steps of:
A method of detecting a subject at risk for opportunistic infection comprising the steps of:
A method of detecting a subject at risk for opportunistic infection comprising the steps of:
A method for predicting an HIV subject at risk for opportunistic infection comprising the steps of:
A method for monitoring an HIV subject at risk for opportunistic infection comprising the steps of:
A method of monitoring a subject at risk for opportunistic infection comprising:
A method for monitoring a subject at risk for opportunistic infection comprising the steps of:
A method of monitoring a subject at risk for opportunistic infection over a period of time comprising the steps of:
A kit for detecting risk of opportunistic infection comprising a container having a panel of antibodies, wherein said antibodies interact with cell surface markers.
A kit for detecting risk of opportunistic infection comprising:
A kit for detecting risk of opportunistic infection comprising at least two different containers, wherein a first container comprises a panel of antibodies to determine cell surface phenotype and a second container comprises markers to determine phagocytosis.
A kit for analyzing monocyte and neutrophil phenotype in an HIV subject comprising a panel of antibodies, wherein said antibodies interact with cell surface markers.
A kit for monitoring risk of opportunistic infection comprising:
A kit for monitoring risk of opportunistic infection comprising at least two different containers, wherein a first container comprises a panel of antibodies to determine cell surface phenotype and a second container comprises markers to determine phagocytosis.
Dependencies are inferred from the claim text.